In conclusion, the AMPK–SIRT1 pathway may be the molecular mechanism of IR in PCOS and may serve as a therapeutic target for developing potential therapies to improve the metabolism and reproductive function of PCOS. Here, SIRT1 is linked to polycystic ovary syndrome.